
Researchers conducted a study on 145 patients with night vision problems, testing the effects of 0.75% phentolamine ophthalmic solution. The trial demonstrated substantial improvement in visual acuity on both evaluation days.

Researchers conducted a study on 145 patients with night vision problems, testing the effects of 0.75% phentolamine ophthalmic solution. The trial demonstrated substantial improvement in visual acuity on both evaluation days.

Data from the study, presented at the 2023 American Academy of Ophthalmology meeting in San Francisco, support the implantation of the LAL in eyes that had undergone a previous RK

OCT and OCTA imaging were especially valuable in this patient population because the images extended the current definition of sickle cell retinopathy.

Light-adjustable lens in patients with previous RK: Improved visual and refractive outcomes after cataract surgery.

News
The clinical trial will evaluate the safety and efficacy of CLS-AX (axitinib injectable suspension), a tyrosine kinase inhibitor. According to the company, topline data is expected during the third quarter of 2024.

Physician notes endothelial cells play key role in hydration, transparency of cornea.

Study results indicated low-light therapy can help prevent dry eye disease following cataract surgery

Innovative new features build on the benefits of the iCare COMPASS Automated Perimeter

Commercial airline pilots work mandates the ability to see clearly at multiple distances from near to far under a variety of conditions. This Case of the Month highlights the impact of prespyopia on visual functions for pilots and that ZEISS PRESBYOND can be a great option to consider improving the ability to perform the full range of their occupational vision-related tasks with high patient satisfaction after surgery.


No two corneal ulcers are alike, but if they are large and centrally located, the common denominator is that time is of the essence

News
According to the company, its Phase I/II trial is being initiated to investigate SpyGlass platform for the long-term delivery of bimatoprost in patients with glaucoma and visually significant cataracts.

By taking a proactive approach to treatment, ophthalmologists can identify the “silent sufferers.”

New drugs are now in the pipeline to focus on treatment of the disease.

Surgeons can save space and optimise workflow efficiency in the operating room

News
According to the company, its ViaLase Laser combines the precision of femtosecond laser technology and the accuracy of micron-level image guidance to deliver the world's first femtosecond laser image-guided high-precision trabeculotomy.

News
Patients who have signs or symptoms of an eye infection after using these products should talk to their health care provider or seek medical care immediately.

News
With the combined system, surgeons will also save space in the operating room and optimize cataract surgery all on one system.

News
Acanthamoeba keratitis can lead to inflammation of the cornea and result in extreme levels of pain, light sensitivity and vision loss.

News
Prevent Blindness is offering videos, fact sheets, social media graphics and PowerPoint presentations to educate the public on the potential effects diabetes may have on vision.

Transparent pricing in elective surgeries is crucial.

The collection at the Truhlsen-Marmor Museum of the Eye includes more than 38,000 objects, including rare books, instruments and immersive educational materials.

When patients pay for elective procedures, premium experience often falters.

Peter J. McDonnell's, MD, Chief medical editor of Ophthalmology times, editorial from the October 2023 issue.

News
According to Genentech, RVO is the third indication for Vabysmo, in addition to wet, or neovascular, age-related macular degeneration and diabetic macular oedema

News
According to Genentech, RVO is the third indication for Vabysmo, in addition to wet, or neovascular, age-related macular degeneration and diabetic macular edema. The approval is based on two Phase III studies demonstrating early and sustained vision improvements that were non-inferior to aflibercept.

BRIO-1 clinical trial sowing optimism as a potential therapeutic option.

News
The collection at the Truhlsen-Marmor Museum of the Eye includes more than 38,000 objects, including rare books, instruments and immersive educational materials.

News
Researchers have delved into the possibility of cell-based therapy in ophthalmology. By targeting vitreoretinal diseases, they are tackling a range of vision-threatening disorders which often result in severe irreversible vision loss.

News
Huang and 2 OCT co-inventors were honored this week at the White House with the National Medal of Technology and Innovation.